The use of Goserelin in the management of endometriosis

Abstract

Zoladex (Goserelin acetate implant) contains a synthetic decapeptide analogue of luteinising hormone releasing (GnRH) agonist analogue. Zoladex is designed for subcutaneous injection (sterile biodegradable product
equivalent to 3.6mg Goserelin)